Search

Author/Creator Sagaert, X

1. O-015A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results. (20th June 2018)

Authors:
Chiritescu, G; Dumon, K; Mercadé, T Macarulla; Lang, I; Vivas, C Santos; Papai, Z; Janssens, J; Hendrickx, K; Pracht, M; Van den Eynde, M; Taïeb, J; Moons, V; Geboes, K; Van Laethem, J; Greil, R; Cervantes, A; Vergauwe, P; Ferrante, M; Vanderstraeten, E; Fridrik, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. PD-032Comparison of surgical data and survival outcome of rectal cancer patients that need upfront surgery after chemoradiotherapy versus salvage surgery after watch-and-wait. (2nd July 2019)

Authors:
Bulens, P; Debucquoy, A; Joye, I; Wolthuis, A; D'Hoore, A; Van Cutsem, E; Dekervel, J; Sagaert, X; Dresen, R; Vandecaveye, V; Deroose, C; Haustermans, K
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 4
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗